REQUEST A DEMO
Total
USD $0.00
Search more companies

Chuang Yi Biotech Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Chuang Yi Biotech Co., Ltd. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Chuang Yi Biotech Co., Ltd. formerly known as Taiwan and Japan Pharmaceutical Industry Co., Ltd., the company mainly engaged in the production of medical products, including intestinal, conditioning, maintenance and strengthening of the immune system and women related products. Chuang Yi Biotech Co., Ltd. was established in 2011 and located in Taipei.

Headquarters
Rm.A,4F., No.3-1, Park St, Nangang Dist
Taipei City; Taipei City;

Contact Details: Purchase the Chuang Yi Biotech Co., Ltd. report to view the information.

Website: http://www.cybiotech.com

Basic Information
Total Employees:
Purchase the Chuang Yi Biotech Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Chuang Yi Biotech Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Chuang Yi Biotech Co., Ltd. report to view the information.
Incorporation Date:
April 28, 2011
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
49.05%
Purchase this report to view the information.
23.12%
Purchase this report to view the information.
4.33%
Purchase this report to view the information.
0.99%
Purchase this report to view the information.
Subsidiaries
Yong Wang Global CORP.
100%
Company Performance
Financial values in the chart are available after Chuang Yi Biotech Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
1.36%
Total operating revenue
1.36%
Operating profit (EBIT)
1.83%
EBITDA
-5.35%
Net Profit (Loss) for the Period
-4.49%
Total assets
6.84%
Total equity
2.6%
Operating Profit Margin (ROS)
0.92%
Net Profit Margin
-0.85%
Return on Equity (ROE)
-0.26%
Quick Ratio
-0.37%
Cash Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?